Skip to main content
$68.49 -$0.73 (-1.1%)

01:00 PM EST on 11/26/21

OptimizeRx Corporation (NASDAQ:OPRX)

CAPS Rating: 5 out of 5

Current Price $68.49 Mkt Cap $1.2B
Open $68.25 P/E Ratio 1,019.83
Prev. Close $68.49 Div. (Yield) $0.00 (0.0%)
Daily Range $65.77 - $68.61 Volume 119,376
52-Wk Range $25.22 - $99.18 Avg. Daily Vol. 429,047

Caps

How do you think NASDAQ:OPRX will perform against the market?

Add Stock to CAPS Watchlist

All Players

32 Outperform
0 Underperform
 

All-Star Players

7 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:OPRX Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:OPRX VS S&P 500 (SPY)

NASDAQ:OPRX Summary

Fools bullish on NASDAQ:OPRX are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about OPRX.

Recs

0
Member Avatar AirplaneMechanic (< 20) Submitted: 10/20/2021 10:05:05 PM : Outperform Start Price: $93.09 NASDAQ:OPRX Score: -28.02

Doctors barely have time to devote to their patients. Anything to increase their efficiency will help increase available doctor to patient face time.

Recs

0
Member Avatar jswinkler16 (35.94) Submitted: 3/25/2021 10:21:43 PM : Outperform Start Price: $47.20 NASDAQ:OPRX Score: +27.70

Huge market opportunity with above market revenue growth.

Recs

0
Member Avatar Leinka (35.69) Submitted: 2/23/2021 9:19:32 AM : Outperform Start Price: $54.96 NASDAQ:OPRX Score: +5.30

Doctors do want to learn about new drugs and devices in their field, but they are so overworked that dealing with sales rep is a nuisance that is tolerated at best because of the goodies they sometimes bring. Electronic health records are the future. Putting these two together, advertising new drugs and devices to doctors over EHR sounds like a major improvement on the status quo, a win for the doctors who can stay up to date and a win for the pharma and biotech companies who get to sell their new products.

Leaderboard

Find the members with the highest scoring picks in OPRX.

Score Leader

fillmorea

fillmorea (24.27) Score: +64.15

The Score Leader is the player with the highest score across all their picks in OPRX.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. FVelociraptor 30.57 1/7/2021 Outperform 5Y $37.79 +81.24% +22.03% +59.20 1 Comment
yoman 21.86 1/12/2021 Outperform 5Y $38.50 +77.90% +21.14% +56.76 0 Comment
VetteNV 44.13 1/19/2021 Outperform 3Y $44.43 +54.15% +21.31% +32.84 0 Comment
tonyk 76.94 7/15/2021 Outperform 5Y $50.03 +36.90% +5.65% +31.24 0 Comment
dvanhoof 23.48 3/29/2021 Outperform 5Y $47.05 +45.57% +16.37% +29.20 0 Comment
jswinkler16 35.94 3/26/2021 Outperform 5Y $47.20 +45.11% +17.40% +27.70 1 Comment
StockBeagle79 65.38 2/1/2021 Outperform 5Y $45.75 +49.70% +22.17% +27.53 1 Comment
ChiefRuby 41.27 1/26/2021 Outperform 5Y $47.40 +44.49% +19.25% +25.24 0 Comment
AygHead 66.48 2/1/2021 Outperform 5Y $46.86 +46.16% +21.78% +24.37 0 Comment
noSPORTSMANSHIP 99.70 2/3/2021 Outperform 3M $48.00 +42.69% +20.01% +22.67 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for OPRX.